MedTrace Logo

Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers

NCT02222844 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 244

Last updated 2024-10-17

No results posted yet for this study

Summary

Patients with suspected or proven sigmoid colon adenocarcinoma, eligible for curative treatment whose MRI can be reviewed prior to surgery and has no decision regarding radical treatment are eligible. Patient are randomised to the control arm which the standard care of preoperative CT imaging and subsequent discussion by the Multidisciplinary Team or the interventional arm which has the additional use of MRI imaging and subsequent discussion by the Multidisciplinary Team. Patients are followed up at 1 and 3 years together with QoL questionnaires.

Conditions

  • Cancer
  • Colorectal Neoplasms
  • Colon, Sigmoid
  • Magnetic Resonance Imaging
  • General Surgery

Interventions

OTHER

Preoperative MRI scan

Standard preoperative CT of abdomen, chest and pelvis plus interventional preoperative MRI scan.

Sponsors & Collaborators

  • Pelican Cancer Foundation

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Gina Brown · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2026-12-31
Completion
2031-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02222844 on ClinicalTrials.gov